These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 31335394)

  • 1. Defining, Identifying, and Understanding "Exceptional Responders" in Oncology Using the Tools of Precision Medicine.
    Tsimberidou AM; Said R; Staudt LM; Conley BA; Takebe N
    Cancer J; 2019; 25(4):296-299. PubMed ID: 31335394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National Cancer Institute's Precision Medicine Initiatives for the new National Clinical Trials Network.
    Abrams J; Conley B; Mooney M; Zwiebel J; Chen A; Welch JJ; Takebe N; Malik S; McShane L; Korn E; Williams M; Staudt L; Doroshow J
    Am Soc Clin Oncol Educ Book; 2014; ():71-6. PubMed ID: 24857062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Exceptional Responders Initiative: Feasibility of a National Cancer Institute Pilot Study.
    Conley BA; Staudt L; Takebe N; Wheeler DA; Wang L; Cardenas MF; Korchina V; Zenklusen JC; McShane LM; Tricoli JV; Williams PM; Lubensky I; O'Sullivan-Coyne G; Kohn E; Little RF; White J; Malik S; Harris LN; Mann B; Weil C; Tarnuzzer R; Karlovich C; Rodgers B; Shankar L; Jacobs PM; Nolan T; Berryman SM; Gastier-Foster J; Bowen J; Leraas K; Shen H; Laird PW; Esteller M; Miller V; Johnson A; Edmondson EF; Giordano TJ; Kim B; Ivy SP
    J Natl Cancer Inst; 2021 Jan; 113(1):27-37. PubMed ID: 32339229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National Cancer Institute Basket/Umbrella Clinical Trials: MATCH, LungMAP, and Beyond.
    Chen AP; Eljanne M; Harris L; Malik S; Seibel NL
    Cancer J; 2019; 25(4):272-281. PubMed ID: 31335391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent innovations in the USA National Cancer Institute-sponsored investigator initiated Phase I and II anticancer drug development.
    Bando H; Takebe N
    Jpn J Clin Oncol; 2015 Nov; 45(11):1001-6. PubMed ID: 26423340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An overview of the NCI precision medicine trials-NCI MATCH and MPACT.
    Do K; O'Sullivan Coyne G; Chen AP
    Chin Clin Oncol; 2015 Sep; 4(3):31. PubMed ID: 26408298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining precision: The precision medicine initiative trials NCI-MPACT and NCI-MATCH.
    Coyne GO; Takebe N; Chen AP
    Curr Probl Cancer; 2017; 41(3):182-193. PubMed ID: 28372823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precision Oncology Medicine: The Clinical Relevance of Patient-Specific Biomarkers Used to Optimize Cancer Treatment.
    Schmidt KT; Chau CH; Price DK; Figg WD
    J Clin Pharmacol; 2016 Dec; 56(12):1484-1499. PubMed ID: 27197880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Profiling of Exceptional Responders to Cancer Therapy.
    Bilusic M; Girardi D; Zhou Y; Jung K; Pei J; Slifker M; Chen Q; Meerzaman D; Alpaugh K; Young D; Flieder D; Gray P; Plimack E
    Oncologist; 2021 Mar; 26(3):186-195. PubMed ID: 33210795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precision medicine in pediatric oncology.
    Forrest SJ; Geoerger B; Janeway KA
    Curr Opin Pediatr; 2018 Feb; 30(1):17-24. PubMed ID: 29189430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Future Approaches to Precision Oncology-Based Clinical Trials.
    Mittra A; Moscow JA
    Cancer J; 2019; 25(4):300-304. PubMed ID: 31335395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precision Medicine in Pediatric Oncology: Translating Genomic Discoveries into Optimized Therapies.
    Tran TH; Shah AT; Loh ML
    Clin Cancer Res; 2017 Sep; 23(18):5329-5338. PubMed ID: 28600472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Pros and Cons of Incorporating Transcriptomics in the Age of Precision Oncology.
    Lin VTG; Yang ES
    J Natl Cancer Inst; 2019 Oct; 111(10):1016-1022. PubMed ID: 31165154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The FDA Oncology Center of Excellence and precision medicine.
    Goldberg KB; Blumenthal GM; McKee AE; Pazdur R
    Exp Biol Med (Maywood); 2018 Feb; 243(3):308-312. PubMed ID: 29105511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspectives on research activity in the USA on Cancer Precision Medicine.
    Bando H; Takebe N
    Jpn J Clin Oncol; 2016 Feb; 46(2):106-10. PubMed ID: 26531706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinical pharmacy pilot within a Precision Medicine Program for cancer patients and review of related pharmacist clinical practice.
    Arnall JR; Petro R; Patel JN; Kennedy L
    J Oncol Pharm Pract; 2019 Jan; 25(1):179-186. PubMed ID: 29078708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current-day precision oncology: from cancer prevention, screening, drug development, and treatment - have we fallen short of the promise?
    Morgan G; Aftimos P; Awada A
    Curr Opin Oncol; 2016 Sep; 28(5):441-6. PubMed ID: 27428363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New clinical trial designs in the era of precision medicine: An overview of definitions, strengths, weaknesses, and current use in oncology.
    Janiaud P; Serghiou S; Ioannidis JPA
    Cancer Treat Rev; 2019 Feb; 73():20-30. PubMed ID: 30572165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precision Oncology Decision Support: Current Approaches and Strategies for the Future.
    Kurnit KC; Dumbrava EEI; Litzenburger B; Khotskaya YB; Johnson AM; Yap TA; Rodon J; Zeng J; Shufean MA; Bailey AM; Sánchez NS; Holla V; Mendelsohn J; Shaw KM; Bernstam EV; Mills GB; Meric-Bernstam F
    Clin Cancer Res; 2018 Jun; 24(12):2719-2731. PubMed ID: 29420224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basket Trials and the MD Anderson Precision Medicine Clinical Trials Platform.
    Said R; Tsimberidou AM
    Cancer J; 2019; 25(4):282-286. PubMed ID: 31335392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.